Eli Lilly and Company
Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis with Baricitinib

Abstract:

Methods of treating Primary Biliary Cholangitis and/or Primary Sclerosing Cholangitis with baricitinib, including formulations and dose regimens. The amount of baricitinib may be administered as a 4 mg tablet or pill that includes one or more excipients. The amount of baricitinib may be administered daily or at some other frequency.